Increased expression of P450scc and CYP17 in development of endogenous hyperandrogenism in a rat model of PCOS

Endocrine

Volumn 43, Issue 1, 2013, Pages 184-190

  Li, Hui ^a,b,c   Chen, Yuan ^a,b   Yan, Li Ying ^a,b   Qiao, Jie ^a,b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c DEZHOU UNIVERSITY   (China)

Author keywords

CYP17; P450scc; Polycystic ovary syndrome; Rat

Indexed keywords

ANDROSTENEDIONE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CHORIONIC GONADOTROPIN; CYTOCHROME P450 17; INSULIN; TESTOSTERONE;

ANDROGEN SYNTHESIS; ANDROSTENEDIONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ESTRUS CYCLE; FEMALE; GRANULOSA CELL; HYPERANDROGENISM; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STROMA CELL; TESTOSTERONE BLOOD LEVEL; THECA CELL; UPREGULATION; WESTERN BLOTTING;

EID: 84872310504     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-012-9739-3     Document Type: Article

References (23)

1. M. Asuncion, R.M. Calvo, J.L. San Millan, J. Sancho et al., A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J. Clin. Endocrinol. Metab. 85(7), 2434-2438 (2000)
2. R. Azziz, K.S. Woods, R. Reyna et al., The prevalence and feature of the polycystic ovary syndrome in an unselected population. J. Clin. Endocrinol. Metab. 89(6), 2745-2749 (2004)
3. A. Huang, K. Brennan, R. Azziz, Prevalence of Hyperandrogenemia in the polycystic ovary syndrome diagnosed by the NIH 1990 criteria. Fertil. Steril. 93(6), 1938-1941 (2010)
4. Y. Chen, J. Qiao, L.Y. Yan et al., Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats. Fertil. Steril. 92(4), 1447-1455 (2009)
5. R.J. Auchus, The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol. Metab. Clin. N. Am. 30(1), 101-119 (2001)
6. F. Durocher, J. Morissette, J. Simard, Genetic linkage mapping of the CYP11A1 gene encoding the cholesterol side-chain cleavage P450scc close to the CYP1A1 gene and D15S204 in the chromosome 15q22.33-q23 region. Pharmacogenetics 8(1), 49-53 (1998)
7. W.L. Miller, Androgen biosynthesis from cholesterol to DHEA. Mol. Cell. Endocrinol. 198(1-2), 7-14 (2002)
8. C. Gilling-Smith, H. Story, V. Rogers et al., Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 47(1), 93-99 (1997)
9. L. Ciotta, A.E. Calogero, M. Farina et al., Clinical, endocrine and metabolic effects of acarbose, an α-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum. Reprod. 16(10), 2066-2072 (2001)
10. D. Romualdi, M. Guido, M. Ciampelli et al., Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum. Reprod. 18(6), 1210-1218 (2003)
11. J.E. Nestler, D.J. Jakubowicz, Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J. Clin. Endocrinol. Metab. 82(12), 4075-4079 (1997)
12. M.H. Lima, L.C. Souza, L.C. Caperuto et al., Up-regulation of the phosphatidylinositol 3-kinase/protein kinase B pathway in the ovary of rats by chronic treatment with hCG and insulin. J. Endocrinol. 190(2), 451-459 (2006)
13. K. Hogg, J.M. Young, E.M. Oliver et al., Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. J. Endocrinol. 153(1), 450-461 (2012)
14. E.R. Hernandez, C.E. Resnick, M.E. Svoboda, Somatomedin-C/insulin-like growth factor-I as an enhancer of androgen biosynthesis by cultured rat ovarian cells. J. Endocrinol. 122(4), 1603-1612 (1988)
15. V.L. Nelson, R.S. Legro, J.F. Strauss et al., Augmented androgen production is a stable steroidogenic phenotype of propagated thecal cells from polycystic ovaries. Mol. Endocrinol. 13(6), 946-957 (1999)
16. L. Poretsky, J. Clemons, K. Bogovich, Hyperinsulinemia and human chorionic gonadotropin synergistically promote the growth of ovarian follicular cyst in rats. Metabolism 41(8), 903-910 (1992)
17. K. Bogovich, J. Clemons, L. Poretsky, Insulin has a biphasic effect on the ability of human chorionic gonadotropin to induce ovarian cysts in the rat. Metabolism 48(8), 995-1002 (1999)
18. R.V. Nemade, O. Carrette, W.J. Larsen et al., Involvement of nitric oxide and the ovarian blood follicle barrier in murine follicular cyst development. Fertil. Steril. 78(6), 1301-1308 (2002)
19. M.-T. Lee, B.C. Bruot, W.C. Adams, Hormonal changes during the early development of ovarian cysts in the rat. Biol. Reprod. 35(3), 542-548 (1986)
20. L. Poretsky, B. Glover, V. Laumas et al., The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I] insulin binding, and ovarian [125I] insulin-like growth-factor I binding in the rat. Endocrinology 122(2), 581-585 (1988)
21. G. Zhang, J.C. Garmey, J.D. Veldhuis, Interactive stimulation by luteinizing hormone and insulin of the steroidogenic acute regulatory (StAR) protein and 17alpha-hydroxylase/17,20-lyase (CYP17) genes in porcine theca cells. Endocrinology 141(8), 2735-2742 (2000)
22. Y. Li, X.Y. Liang, L.N. Wei et al., Study of RNA interference inhibiting rat ovarian androgen biosynthesis by depressing 17alpha-hydroxylase/17,20-lyase activity in vivo. Reprod. Biol. Endocrinol. 17(7), 73 (2009)
23. M.J. Young, A.S. Mcneilly, Theca: the forgotten cell of the ovarian follicle. Reproduction 140(4), 489-504 (2010)